| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $174.0M | +58.4% |
| R&D Expense | $27.5M | +21.2% |
| SG&A Expense | $65.8M | +85.0% |
| Operating Income | -$29.9M | -74.3% |
| Interest Expense | $80K | -97.3% |
| Pre-tax Income | -$21.5M | +66.6% |
| Income Tax | -$82K | +63.7% |
| Net Income | -$22.0M | +65.7% |
| EPS (Basic) | -$0.12 | +83.3% |
| EPS (Diluted) | -$0.12 | +83.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.9M | -78.9% |
| Short-term Investments | $191.3M | — |
| Accounts Receivable | $53.2M | +104.4% |
| Current Assets | $312.0M | +0.3% |
| Total Assets | $418.3M | +5.3% |
| Current Liabilities | $87.1M | +46.7% |
| Long-term Debt | $0 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.7M | -88.5% |
| Capital Expenditures | $614K | -30.3% |
| Investing Cash Flow | -$225.0M | -1857.9% |
| Financing Cash Flow | $3.4M | -98.3% |
| Free Cash Flow | $1.0M | -92.3% |
| Total Liabilities |
| $110.0M |
| +5.2% |
| Stockholders' Equity | $308.3M | +5.4% |